A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis
Condition(s):Scleroderma, Systemic; Skin Sclerosis; Lung Fibrosis; Autoimmune Diseases; Collagen DiseasesLast Updated:February 18, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Scleroderma, Systemic; Skin Sclerosis; Lung Fibrosis; Autoimmune Diseases; Collagen DiseasesLast Updated:February 18, 2020Completed
Condition(s):Systemic SclerosisLast Updated:March 9, 2020Completed
Condition(s):Colitis, UlcerativeLast Updated:February 17, 2021Active, not recruiting
Condition(s):Gastroesophageal Reflux Disease (GERD)Last Updated:June 2, 2014Completed
Condition(s):Individual Differences; Pain; Stress; ImpulsivityLast Updated:January 5, 2021Completed
Condition(s):Sleep Initiation and Maintenance Disorders; Sleep DisordersLast Updated:August 20, 2014Completed
Condition(s):Partial EpilepsyLast Updated:September 20, 2019Active, not recruiting
Condition(s):Multiple SclerosisLast Updated:June 25, 2012Completed
Condition(s):Episodic MigraineLast Updated:June 14, 2016Unknown status
Condition(s):Sleep Initiation and Maintenance DisordersLast Updated:August 20, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.